Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU ...Middle East

SHANGHAI, Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced the...

Hence then, the article about asieris releases phase iii clinical study and real world research data for apl 1706 a bladder cancer diagnosis and management drug at the 2024 asco gu was published today ( Monday 29/01/2024 - 11:25 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU )

Also on site :

• My Big Family Once Formed the Backbone of My Life. Then, We Discovered My Sister’s Horrific Actions. Now Nothing Is the Same.
• Royal Caribbean Extends Pause at Private Caribbean Resort Through 2026—Here’s What Cruisers Are Getting Instead
• HomeGoods' Gorgeous New Valentine's Glassware Has Shoppers Saying: 'I Need It All'